Nordihydroguaiaretic acid - CAS# 500-38-9 tabolite Hydroxy Iloperidone PD 0332991 isethionate

PD 0332991 isethionate

including radiation and DNA alkylation

whereas the absence of P-gp causes a 6-fold increase in the plasma concentration and 3-fold higher brain-to-plasma concentration ratio after oral administration

P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist

PF-3845 is a fatty acid amide hydrolase (FAAH) inhibitor

Nordihydroguaiaretic acid - CAS# 500-38-9 tabolite Hydroxy Iloperidone PD 0332991 isethionateEtrasimod, also known as APD334, is a potent, centrally available, functional antagonists of the S1P1 receptor for use as next generation therapeutics for treating multiple sclerosis (MS) and other autoimmune diseases. APD334 has a favorable PK PD profile, producing robust lymphocyte lowering at relatively low plasma concentrations in several preclinical species. APD334 was efficacious in a mouse experimental autoimmune encephalomyelitis (EAE) model